A closed-door discussion uniting top C-level executives from biotech to discuss the most pressing challenges and advancements shaping the CAR-TCR field in Europe. This year’s Think Tank explores Tregs in autoimmune disease to understand how they can be leveraged as therapies and their significance when other effector cell therapies are used.

Invite Only